Blue Tokai began with a 500-gram roaster in a Delhi home and grew into a multi-format coffee business spanning cafés, packaged beans, subsc...

The deal will value Blue Tokai chain at up to Rs 3,700 crore. This will be the largest round for the roasters so far, and will involve a co...

India Private Equity Investment 2026: Geopolitical risks now shape private equity deal considerations in India. Investors increasingly focu...

Will be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.

The fund has secured commitments of Rs 650-700 crore from family offices, including those of former Bharti Enterprises vice chairman Akhil ...

ChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...

Amid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....

Standard Chartered India is witnessing a series of senior leadership exits as it reshapes its wealth business and moves away from mass-mark...

Bankers and investors told ET that interest is expanding beyond capital-intensive AI infrastructure to applications that automate business ...

Bastian Hospitality is raising capital from investors for expansion plans. The fine-dining chain aims to sell a minority stake to support g...

The deal, a mix of primary and secondary transactions, values WOW Skin Science at Rs 900 crore for its India and rest of the world business...

The fund size could go up to $950 million with the firm’s four partners also planning to contribute $50-100 million, the people added.

ChrysCapital's $30-million cheque in the L&T Infotech IPO marks its return to public market investing after big, profitable exits from Info...

Temasek acquired the stake by way of secondary purchase of shares from private equity investor ChrysCapital. This investment will deepen Te...

FMCG firm CavinKare today said Mauritius-based private equity firm ChrysCapital has invested Rs 250 crore in it for an undisclosed stake

3 PE firms are vying for a minority stake in generic drugmaker Intas Pharmaceuticals, two people familiar with the development told ET.

Private equity fund manager, ChrysCapital, has acquired a 10 per cent stake in Kolkata-based Titagarh Wagons and plans to invest over $500 ...